As 2025 draws to a close, we look back at a year marked by strong scientific progress, meaningful engagement, and growing momentum for improving early detection of pancreatic cancer.
The year began with a major milestone: PANCAID’s Stakeholder Dialogue Event at the European Parliament in Brussels, which brought together 55 participants from 21 countries and 31 organisations, including patient advocates, healthcare providers, industry, medical societies, and public institutions. The discussions highlighted four urgent priorities for advancing early detection: increased research funding, sustained collaboration across Europe, greater awareness and education, and stronger policy integration. These insights later informed a PANCAID Call-to-Action paper capturing the event’s key messages.
Scientific output continued to grow, with two peer-reviewed publications released this year:
Our visibility and outreach expanded as well. On social media, we completed the PANCAID Partner Spotlight series, introducing the people and institutions driving the project. PANCAID researchers were also active at major scientific conferences throughout the year, including ISMRC, ESMO, and UEG Week, ensuring our work was shared across key communities.
In November, the project reached another cluster milestone: on World Pancreatic Cancer Day, PANCAID hosted the 3rd Annual Prevention & Early Detection (Screening) Cluster Meeting, following directly after our 4th General Assembly Meeting. These back-to-back gatherings reinforced collaboration across Mission Cancer projects and aligned plans for the coming year.
We extend our sincere thanks to everyone who contributed to PANCAID’s progress in 2025. We look forward to continuing this work together as we move into an important year ahead.
